Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Amber Kanwar's 'deep' dive into CXR pricing
View:
Post by cashflow98 on May 06, 2016 10:44am

Amber Kanwar's 'deep' dive into CXR pricing

https://www.bnn.ca/News/2016/5/6/Concordia-Healthcare-Diving-deep-into-claims-of-sky-high-prices.aspx
Comment by Marcel7 on May 06, 2016 10:53am
Well there is this: "In fact, since Concordia took ownership in October, the price of the pink eye drug, Fucithalmic, is actually unchanged. The price increased 50 per cent right before Concordia took ownership." Marcel
Comment by Pj1958 on May 06, 2016 11:01am
LETTUCE AND COMPANY.... And was ridiculed for saying that the price hikes were done by AMCo prior to CXR buying them out....OF COURSE IT MATTERS WHO RAISES THE PRICES. CXR only raised prices on 2 drugs since the buyout , and they shouldn't  be smeared by the short and distort gang for price increases that they are not responsible for.
Comment by Lattice on May 06, 2016 11:15am
This post has been removed in accordance with Community Policy
Comment by Pj1958 on May 06, 2016 12:02pm
LETTUCE.....wrong again.... They did not raise 59%... I don't know where you're reading skills were acquired... But they only increased the price of 2 medications since they bought AMCo's 160 drugs. 30% on each. You may want to read the article slowly , the other raises were done prior to the purchase. Short and distort again.
Comment by Lattice on May 06, 2016 12:26pm
This post has been removed in accordance with Community Policy
Comment by digitel on May 06, 2016 11:03am
This post has been removed in accordance with Community Policy
Comment by Craigbad on May 06, 2016 11:03am
Doesn't seem to matter at this point, everytime the stock is mentioned in the news it seems to tank. The article makes some good points on volume vs price, but it leaves you feeling that the waters are a little muddy and investors don't seem to have the appetite to dive in at this point for fear of breaking their neck. I'd like to see more support at $33 because the next stop is $30 ...more  
Comment by Lesalpes29 on May 06, 2016 11:10am
Very good analysis craby. Ignore list is your place now!
Comment by adamchess on May 06, 2016 12:41pm
So, it is true that "Concordia" DID NOT INCREASE the price of the pink-eye drug at all during its ownership of AMCo since October 2015. The British Financial Times knows this full well or ought to have known this. Obviously, a bunch of fraudsters trying to add to the short and distort regime that rips off retail investors. Where is the IIROC and OSC protecting our interests? Do your job ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities